Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Yumanity Therapeutics Q3 EPS $(0.31) Up From $(0.97) YoY, Sales $1.40M Down From $1.64M YoY

Author: Benzinga Newsdesk | November 14, 2022 09:28am
Yumanity Therapeutics (NASDAQ:YMTX) reported quarterly losses of $(0.31) per share. This is a 68.04 percent increase over losses of $(0.97) per share from the same period last year. The company reported $1.40 million in sales this quarter. This is a 14.25 percent decrease over sales of $1.64 million the same period last year.

Posted In: YMTX


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist